Pharma & Biotech

Shares of Cardiff Oncology advanced 1.96% in the latest session, moving from $2.04 to $2.08. However, this modest upward move...

A strategic legal agreement has positioned pharmaceutical giant AbbVie for exceptional financial performance through the next decade. In a development...

Shares of Edgewise Therapeutics saw significant upward movement in today's trading session, closing at $15.57 for a notable gain of...

Shares of Australian biotechnology firm CSL are experiencing intense selling pressure, driving the stock to its lowest valuation in six...

Shares of clinical-stage biopharmaceutical company Immuneering Corporation are posting significant gains today, advancing 2.46% to trade at $8.34. This upward...

While Precigen recently secured a $125 million credit facility and gained full FDA approval for its flagship product, AdenoVerse™ PRZIME™...

Danish pharmaceutical giant Novo Nordisk has unveiled a sweeping workforce reduction plan that will eliminate approximately 9,000 positions, representing about...

Telehealth innovator Hims & Hers Health is pursuing a significant expansion opportunity that could unlock substantial new revenue streams. Rather...

As its share price continues to struggle, Illumina is making a decisive strategic move by entering the human protein measurement...

Assembly Biosciences shares are experiencing a significant correction phase. The biotechnology stock has now recorded losses for three consecutive trading...